Table 14:
Post-test Probabilities of Disease With CAP, Given Varying Pre-test Probabilitiesa
| CAP Steatosis Stage | Assumed Pre-test Probability | Positive Disease Results | Negative Disease Results | ||
|---|---|---|---|---|---|
| Positive LR (95% CI) | Post-test Probability of Disease | Negative LR (95% CI) | Post-test Probability of Disease | ||
| ≥ S1 | 25% | 3.61 (2.4–5.44) | 55% | 0.29 (0.20–0.40) | 9% |
| 50% | 78% | 22% | |||
| 75% | 92% | 46% | |||
| ≥ S2 | 25% | 4 (NR) | 58% | 0.3 (NR) | 6% |
| 50% | 80% | 16% | |||
| 75% | 92% | 37% | |||
| ≥ S3 | 25% | 4 (NR) | 57% | 0.3 (NR) | 7% |
| 50% | 80% | 17% | |||
| 75% | 92% | 39% | |||
Abbreviations: CAP, controlled attenuation parameter; CI, confidence interval; LR, likelihood ratio; NR, not reported.
a
Table data from the systematic review by Shi et al. (41)